Skip to content

Friday, July 26, 2024

Latest:

Reflections on medical advocacy
Congratulations, Dr. James R. Lupski, 2024 Mendel Lecturer and recipient of the Gilded Pea Award!
Benefits of low impact workouts: Pilates, dance and barre
Eating healthy on a budget: Tips and tricks from a registered dietitian
Defective serotonin 2C receptors lead to memory deficits in mice and humans

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

pediatric liver cancer

Novel combination therapy offers promising results for treatment-refractory hepatoblastoma

February 20, 2024 Chemotherapy, HDAC, hepatoblastoma, panobinostat, pediatric liver cancer, Research

Hepatoblastoma (HB) is the most common liver cancer in children. Researchers and physicians in the field are concerned because in the last decade HB has

Molecular profiling identifies new high-risk subtype of pediatric liver cancer

May 24, 2022 cancer treatment, diagnostic algorithm for cancer, hepatoblastoma, hepatocellular carcinoma, molecular profiling, pediatric liver cancer, Research

The findings support a diagnostic algorithm to identify the cancer subtype and guide specialized treatment.

From the Labs: Image of the Month

From the Labs: The wooly mammoth emerges from the past.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951